FDA Approves Oral Combination of Decitabine and Cedazuridine Tablets with Venetoclax for Newly Diagnosed AML By Ogkologos - June 3, 2026 76 0 Facebook Twitter Google+ Pinterest WhatsApp Evidence for efficacy is based on the results from the Study ASTX727-07 Source RELATED ARTICLESMORE FROM AUTHOR How Decades of NCI Support Led to Groundbreaking Discoveries: The Story of Immune Checkpoint Inhibitors Adding Belzutifan to Pembrolizumab Prolongs DFS After Nephrectomy in Patients with ccRCC at Increased Risk for Recurrence Aiming to Improve Cancer Prevention, ESMO Calls for Strong Policy Measures to Fight the Tobacco Epidemic in Feedback on the EU Tobacco Products and... MOST POPULAR Same Breast Cancer, Same Place, Same Treatment. This Mother and Daughter... May 7, 2021 Study Suggests Statins May Help Keep Breast Cancer from Spreading to... June 24, 2020 The power of partnership – the unique alliance taking on brain... December 15, 2022 EMA’s Safety Committee Has Concluded That the Benefits of Ifosfamide Solutions... March 16, 2021 Load more HOT NEWS Company Gives Cancer Patient a New HVAC System After Treatment and... Combination immunotherapy for advanced bowel cancer approved for NHS in England Cancer in My Community: Overcoming Delays in Care for Children With... First Global Estimates of Cervical Cancer Attributable to HIV
